Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hiddemann

Showing results (81-90 of 533) with videos related to

Pageof 54
Sort By:
Praxis|July 9, 1998
[Systemic therapy of low malignancy non-Hodgkin lymphomas]B Wörmann, C Buske, W Hiddemann
Der Internist|May 8, 2012
[Sport as therapy for internal diseases]H Löllgen, W Hiddemann, K Werdan
Deutsche Medizinische Wochenschrift (1946)|April 15, 2005
[Mutations of the gene coding for the receptor tyrosine kinase FLT3 in acute myeloid leukemia. Significance as the disease-specific molecular marker for diagnosis, prognosis and innovative therapy approaches]K Spiekermann, W Hiddemann, S Schnittger
Medizinische Klinik (Munich, Germany : 1983)|May 2, 1998
[Clinical studies in oncology. Relevance, design, ethical considerations]B Wörmann, G Wulf, W Hiddemann
Praxis|March 19, 1996
[Therapy of low-grade non-Hodgkin lymphomas]W Hiddemann, M Unterhalt, B Wörmann
Deutsche Medizinische Wochenschrift (1946)|June 12, 2009
[Hematology 2009]M Dreyling, K Spiekermann, W Hiddemann
Leukemia Research|January 1, 1991
Reversible leukaemic regrowth under GM-CSF treatment after chemotherapy for AMLM Koenigsmann, W Hiddemann, T Büchner
Annals of Hematology|December 12, 2003
Mantle cell lymphoma: established therapeutic options and future directionsG Lenz, M Dreyling, W Hiddemann
Der Internist|August 10, 2000
[Palliative psychooncology--demand and methods. Beginning anew at the end?]U Gruber, T Vollmer, W Hiddemann
British Journal of Haematology|July 11, 2000
Prognostic significance of cytogenetics in relapsed acute myeloid leukaemiaW Kern, C Schoch, W Hiddemann
Pageof 54

Showing results (81-90 of 533) with videos related to

Sort By:
Pageof 54
Praxis|July 9, 1998
[Systemic therapy of low malignancy non-Hodgkin lymphomas]B Wörmann, C Buske, W Hiddemann
Der Internist|May 8, 2012
[Sport as therapy for internal diseases]H Löllgen, W Hiddemann, K Werdan
Deutsche Medizinische Wochenschrift (1946)|April 15, 2005
[Mutations of the gene coding for the receptor tyrosine kinase FLT3 in acute myeloid leukemia. Significance as the disease-specific molecular marker for diagnosis, prognosis and innovative therapy approaches]K Spiekermann, W Hiddemann, S Schnittger
Medizinische Klinik (Munich, Germany : 1983)|May 2, 1998
[Clinical studies in oncology. Relevance, design, ethical considerations]B Wörmann, G Wulf, W Hiddemann
Praxis|March 19, 1996
[Therapy of low-grade non-Hodgkin lymphomas]W Hiddemann, M Unterhalt, B Wörmann
Deutsche Medizinische Wochenschrift (1946)|June 12, 2009
[Hematology 2009]M Dreyling, K Spiekermann, W Hiddemann
Leukemia Research|January 1, 1991
Reversible leukaemic regrowth under GM-CSF treatment after chemotherapy for AMLM Koenigsmann, W Hiddemann, T Büchner
Annals of Hematology|December 12, 2003
Mantle cell lymphoma: established therapeutic options and future directionsG Lenz, M Dreyling, W Hiddemann
Der Internist|August 10, 2000
[Palliative psychooncology--demand and methods. Beginning anew at the end?]U Gruber, T Vollmer, W Hiddemann
British Journal of Haematology|July 11, 2000
Prognostic significance of cytogenetics in relapsed acute myeloid leukaemiaW Kern, C Schoch, W Hiddemann
Pageof 54